Page last updated: 2024-09-05

erlotinib hydrochloride and argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-

erlotinib hydrochloride has been researched along with argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)	Trials (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)	Recent Studies (post-2010) (argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)
4,353	786	3,033	14	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benveniste, MF; Carter, BW; de Groot, PM; Shroff, GS; Truong, MT; Viswanathan, C; Wu, CC	1

Reviews

1 review(s) available for erlotinib hydrochloride and argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-

Article	Year
Imaging on Lung Cancer and Treatment with Targeted Therapy. Seminars in ultrasound, CT, and MR, 2018, Volume: 39, Issue:3 Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Agents, Immunological; Arginine Vasopressin; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Crizotinib; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung; Lung Neoplasms; Mutation; Tomography, X-Ray Computed	2018

Article

Year

Imaging on Lung Cancer and Treatment with Targeted Therapy.

Seminars in ultrasound, CT, and MR, 2018, Volume: 39, Issue:3

Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Agents, Immunological; Arginine Vasopressin; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Crizotinib; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung; Lung Neoplasms; Mutation; Tomography, X-Ray Computed

2018